| Thromboembolic complications in patients with newly diagnosed dilated cardiomyopathy immediately after initiation of congestive heart failure treatment: just a coincidence or should we pay more attention? | |
| | |
MedLine Citation:
|
PMID: 19520683 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Recently, we have experienced cerebrovascular embolic events in 2 consecutive patients in our outpatient clinic. Accordingly, we want to share our comments with literature on these 2 patients. Both patients had newly diagnosed left ventricular (LV) dysfunction, sinus rhythm, and cerebrovascular event within the first week after initiation of heart failure treatment. Although, our cases are not enough to make a general statement or conclusion, we can recommend that patients with newly diagnosed severe LV dysfunction with normal sinus rhythm and without echocardiographically visible thrombus should also be closely followed up for thromboembolic complications at least during the first weeks of congestive heart failure treatment. |
| | |
Authors:
|
Ertan Yetkin; Ergun Topal; Ahmet Yanik; Mahmut Ozten |
Related Documents
:
|
1423423 - Aortic input impedence and neurohormonal activation in patients with mild to moderate c... 3810693 - Experimental study on the effects of the extracorporeal ultrafiltration method in advan... 2935603 - Assessment of cardiac status in hypertensive patients. |
Publication Detail:
|
Type: Case Reports; Journal Article Date: 2009-06-10 |
Journal Detail:
|
Title: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis Volume: 16 ISSN: 1938-2723 ISO Abbreviation: Clin. Appl. Thromb. Hemost. Publication Date: 2010 Aug |
Date Detail:
|
Created Date: 2010-07-21 Completed Date: 2010-11-22 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9508125 Medline TA: Clin Appl Thromb Hemost Country: United States |
Other Details:
|
Languages: eng Pagination: 480-2 Citation Subset: IM |
Affiliation:
|
Department of Cardiology, International Medical Center, Mersin, Turkey. ertanyetkin@hotmail.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Anticoagulants
/
therapeutic use Cardiomyopathy, Dilated / blood*, drug therapy*, physiopathology Heart Failure / blood*, drug therapy*, physiopathology Humans Male Middle Aged Thromboembolism / complications*, therapy Ventricular Dysfunction, Left / drug therapy, physiopathology |
| Chemical | |
Reg. No./Substance:
|
0/Anticoagulants |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Stability of plasma anti-Xa activity in low-molecular-weight heparin monitoring.
Next Document: Role of Thrombotic Risk Factors in End-Stage Renal Disease.